Thomas E. Johns

1.1k total citations
14 papers, 820 citations indexed

About

Thomas E. Johns is a scholar working on Emergency Medical Services, Geriatrics and Gerontology and Surgery. According to data from OpenAlex, Thomas E. Johns has authored 14 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Emergency Medical Services, 6 papers in Geriatrics and Gerontology and 3 papers in Surgery. Recurrent topics in Thomas E. Johns's work include Patient Safety and Medication Errors (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Medical Malpractice and Liability Issues (3 papers). Thomas E. Johns is often cited by papers focused on Patient Safety and Medication Errors (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Medical Malpractice and Liability Issues (3 papers). Thomas E. Johns collaborates with scholars based in United States and Thailand. Thomas E. Johns's co-authors include Almut G. Winterstein, Ricardo J. Gonzalez‐Rothi, Randy C. Hatton, Richard Segal, Penkarn Kanjanarat, Catherine A. Hammett‐Stabler, Eric I. Rosenberg, Amy F. Rosenberg, Marc Zumberg and Neil Harris and has published in prestigious journals such as Clinical Chemistry, PharmacoEconomics and Annals of Pharmacotherapy.

In The Last Decade

Thomas E. Johns

14 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Johns United States	11	327	262	158	116	108	14	820
David Cousins United Kingdom	12	324 1.0×	376 1.4×	40 0.3×	142 1.2×	94 0.9×	21	849
Michael Barras Australia	20	541 1.7×	137 0.5×	66 0.4×	325 2.8×	178 1.6×	96	1.5k
Kheirollah Gholami Iran	20	340 1.0×	111 0.4×	212 1.3×	72 0.6×	185 1.7×	71	1.2k
Thomas J. Schroeder United States	6	376 1.1×	157 0.6×	166 1.1×	98 0.8×	190 1.8×	10	820
Adriano Max Moreira Reis Brazil	21	658 2.0×	177 0.7×	104 0.7×	123 1.1×	233 2.2×	116	1.3k
Sherrie L. Aspinall United States	22	618 1.9×	68 0.3×	118 0.7×	212 1.8×	138 1.3×	63	1.4k
Jacob Abarca United States	15	682 2.1×	287 1.1×	158 1.0×	196 1.7×	209 1.9×	31	1.2k
Stéphane Steurbaut Belgium	19	421 1.3×	172 0.7×	81 0.5×	475 4.1×	107 1.0×	76	1.1k
Kheirollah Gholami Iran	15	176 0.5×	64 0.2×	95 0.6×	66 0.6×	79 0.7×	64	663
Brigitte Sabatier France	20	487 1.5×	363 1.4×	41 0.3×	163 1.4×	91 0.8×	69	1.2k

Countries citing papers authored by Thomas E. Johns

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Johns more than expected).

Fields of papers citing papers by Thomas E. Johns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Johns. The network helps show where Thomas E. Johns may publish in the future.

Co-authorship network of co-authors of Thomas E. Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Johns. A scholar is included among the top collaborators of Thomas E. Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Johns. Thomas E. Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Johns, Thomas E., et al.. (2017). Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals. American Journal of Health-System Pharmacy. 74(21). 1774–1783. 11 indexed citations

Winterstein, Almut G., Dandan Xu, Gloria Lipori, et al.. (2017). Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events. American Journal of Health-System Pharmacy. 74(23). 1970–1984. 18 indexed citations

Winterstein, Almut G., et al.. (2015). Development of a Medication Safety and Quality Survey for Small Rural Hospitals. Journal of Patient Safety. 13(4). 249–254. 2 indexed citations

Rosenberg, Amy F., et al.. (2011). Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion. Annals of Pharmacotherapy. 45(7-8). 861–868. 106 indexed citations

Hartzema, Abraham G., et al.. (2007). Planning for pharmacy health information technology in critical access hospitals. American Journal of Health-System Pharmacy. 64(3). 315–321. 10 indexed citations

Winterstein, Almut G., et al.. (2006). Medication safety infrastructure in critical-access hospitals in Florida. American Journal of Health-System Pharmacy. 63(5). 442–450. 10 indexed citations

Smith, Wendy D., Almut G. Winterstein, Thomas E. Johns, Eric I. Rosenberg, & Brian C. Sauer. (2005). Causes of hyperglycemia and hypoglycemia in adult inpatients. American Journal of Health-System Pharmacy. 62(7). 714–719. 85 indexed citations

Segal, Richard, et al.. (2004). Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia. PharmacoEconomics. 22(11). 751–757. 46 indexed citations

Winterstein, Almut G., Thomas E. Johns, Eric I. Rosenberg, et al.. (2004). Nature and causes of clinically significant medication errors in a tertiary care hospital. American Journal of Health-System Pharmacy. 61(18). 1908–1916. 85 indexed citations

10.

Kanjanarat, Penkarn, Almut G. Winterstein, Thomas E. Johns, et al.. (2003). Nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacy. 60(17). 1750–1759. 218 indexed citations

11.

Winterstein, Almut G., Randy C. Hatton, Ricardo J. Gonzalez‐Rothi, Thomas E. Johns, & Richard Segal. (2002). Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports. American Journal of Health-System Pharmacy. 59(18). 1742–1749. 109 indexed citations

12.

Hammett‐Stabler, Catherine A. & Thomas E. Johns. (1998). Laboratory guidelines for monitoring of antimicrobial drugs. Clinical Chemistry. 44(5). 1129–1140. 86 indexed citations

13.

Bell, Dawn, Thomas E. Johns, & Larry M. Lopez. (1998). Endothelial Dysfunction: Implications for Therapy of Cardiovascular Diseases. Annals of Pharmacotherapy. 32(4). 459–470. 22 indexed citations

14.

Johns, Thomas E. & Larry M. Lopez. (1995). Bisoprolol: Is This Just Another Beta-Blocker for Hypertension or Angina?. Annals of Pharmacotherapy. 29(4). 403–414. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact